Uncategorized
IIVS Appointed to China’s Alternatives Working Group for Cosmetics
October 9, 2018Gaithersburg, MD – October 9, 2018 – U.S. based Institute for In Vitro Sciences (IIVS) has been invited by China’s National Institute for Food and Drug Control (NIFDC) to join their working group on alternatives for cosmetics. The newly established group was announced by the NIFDC during their 2nd International Conference on Cosmetics Alternative Methods held in Beijing in September. Chaired by NIFDC Vice Director, Lu Yong, the working group also includes representatives from several provincial government agencies and companies...
Webinar: Precision-cut Lung Slices
October 5, 2018Dr. Holger Behrsing, Principal Scientist with IIVS, recently presented "Precision-cut Lung Slices (PCLS)" for the 2018 PETA International Science Consortium webinar series on non-animal inhalation testing methods. ...
IIVS Hosts Quarterly Meeting for SQA’s Computer Validation and IT Compliance (CVIC) Specialty Section
October 4, 2018The CVIC agenda included a presentation and follow-up discussion on artificial intelligence and computer learning and their use in regulated industry, a panel discussion of cloud computing adoption in “GxP” environments, and open discussion on the use of the “Internet of Things” and data integrity and governance concepts. In addition to the CVIC member, an FDA representative was on site to gather industry input on specific topics. IIVS is pleased to support activities like this through the Society of Quality Assurance. If...
Encouraging Regulatory Acceptance of Non-Animal Testing Methods Discussed at Annual SACATM Meeting
October 2, 2018Among the topics discussed at the annual Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) meeting held in early September was ways to encourage both regulators and regulated industry to use new approach methodologies (NAMs). The meeting brought together experts from academia, industry, and animal welfare organizations and the importance of collaboration among the different groups and geographical regions was a recurring theme. Learn more...
California Passes Ban on Cosmetics Tested on Animals
October 1, 2018California now has the most stringent cruelty-free policies in the U.S., following Governor Jerry Brown's signing of the bill banning the sale of cosmetic products and ingredients tested on animals. The California Cruelty-Free Cosmetics Act brings California in line with the EU and other global standards but still includes some exemptions for animal tests conducted to achieve compliance with other bodies, leaving some unanswered questions. Learn more...
IIVS Collaborates with BASF and Givaudan to Validate a Non-animal Test for Regulatory Submissions
August 28, 2018GAITHERSBURG, MD –August 28– The Institute for In Vitro Sciences (IIVS), with an established track record in the validation of alternatives to animal testing, is teaming up with BASF and Givaudan to validate an improved skin sensitization reactivity method to address the needs of toxicologists and regulators. Scientists at BASF and Givaudan have developed the Kinetic Direct Peptide Reactivity Assay (Kinetic DPRA), a non-animal test to predict allergic reactions in the skin known as sensitization. Three other non-animal sensitizer tests have...
2018 Lush Prize Shortlist Announced
August 7, 2018This year saw entries for the first time from Lebanon, Sri Lanka, and Turkey as the reach of the Lush Prize continues to grow. From the many entrants, reviewers have selected a shortlist of 56 projects and 17 scientists across five award categories who go through to the final judging phase. Winners will be announced in November. Learn More....
Modernization of EPA “6-Pack” of Acute Toxicity Tests Continues
July 27, 2018The US Environmental Protection Agency (US EPA) continues to drive significant efforts in the United States to modernize the battery of acute toxicity tests classically known as the “6-pack.” Learn More....
Tiered In Vitro Testing Strategy For Assessing The Ocular and Dermal Irritation/Corrosion Potential of Pharmaceutical Compounds
July 23, 2018Read our latest publication with Bristol-Myers Squibb regarding a tiered testing strategy for occupational hazards of pharmaceutical intermediates now published in the Cutaneous and Ocular Toxicology Journal. Irritation reactions are a frequently reported occupational illness. The potential adverse effects of pharmaceutical compounds (PCs) on employees' eyes and skin can now be assessed using validated in vitro methods. Our overall aim is to reduce animal testing by replacing the historically utilized in vivo test methods with validated in vitro test methods which accurately determine the ocular...
FutureTox IV Registration and Abstract Submission Now Open
July 23, 2018The Society of Toxicology's FutureTox IV Progress to Maturity: Predictive Developmental and Reproductive Toxicology for Healthy Children is being held in Arlington, VA from November 14 until November 16, 2018. The meeting will focus, among other things, on the impact of environmental factors on developmental health and current translational opportunities and challenges for in vitro data and in silico models in developmental effects assessment and regulatory decision-making for toxicity testing. The Key Note Lectures will be: Assessing Children's Health Trajectories in the Context of Regulatory Decision-Making. Susan...